USA - NYSE:MCK - US58155Q1031 - Common Stock
MCK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of MCK get a neutral evaluation. Nothing too spectacular is happening here. MCK is not overvalued while it is showing excellent growth. This is an interesting combination. This makes MCK very considerable for growth investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.89% | ||
ROE | N/A | ||
ROIC | 24.26% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 1.34% | ||
PM (TTM) | 0.84% | ||
GM | 3.46% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | 1.37 | ||
Altman-Z | 5.74 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.88 | ||
Quick Ratio | 0.49 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 22 | ||
Fwd PE | 17.32 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 16.17 | ||
EV/EBITDA | 17.63 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.48% |
736.52
-24.06 (-3.16%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.48% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 22 | ||
Fwd PE | 17.32 | ||
P/S | 0.24 | ||
P/FCF | 16.17 | ||
P/OCF | 13.99 | ||
P/B | N/A | ||
P/tB | N/A | ||
EV/EBITDA | 17.63 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.89% | ||
ROE | N/A | ||
ROCE | 29.72% | ||
ROIC | 24.26% | ||
ROICexc | 28.29% | ||
ROICexgc | N/A | ||
OM | 1.34% | ||
PM (TTM) | 0.84% | ||
GM | 3.46% | ||
FCFM | 1.5% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | 1.37 | ||
Debt/EBITDA | 1.15 | ||
Cap/Depr | 141.19% | ||
Cap/Sales | 0.23% | ||
Interest Coverage | 250 | ||
Cash Conversion | 115.45% | ||
Profit Quality | 179.08% | ||
Current Ratio | 0.88 | ||
Quick Ratio | 0.49 | ||
Altman-Z | 5.74 |